Dr. Bissell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
350 Parnassus Ave
San Francisco, CA 94117Phone+1 415-353-2318Fax+1 415-353-2407
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 1970 - 1973
- Boston University Medical CenterResidency, Internal Medicine, 1968 - 1970
- Boston University Medical CenterInternship, Transitional Year, 1967 - 1968
- Harvard Medical SchoolClass of 1967
Certifications & Licensure
- CA State Medical License 1970 - 2020
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Longitudinal Study of the Porphyrias Start of enrollment: 2010 Nov 01
- Clinical Diagnosis of Acute Porphyria Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 46 citationsEfficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION studyPaolo Ventura, Herbert L. Bonkovsky, Laurent Gouya, Paula Aguilera-Peiró, D. Montgomery Bissell
Liver International. 2021-10-30 - 28 citationsHepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium.Behnam Saberi, Hetanshi Naik, Jessica Overbey, Angelika Erwin, Karl E. Anderson
Hepatology. 2021-05-01 - 296 citationsPhase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent PorphyriaManisha Balwani, Eliane Sardh, Paolo Ventura, Paula Aguilera Peiró, David C. Rees
The New England Journal of Medicine. 2020-06-10
Grant Support
- Liver CenterNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2005
- Cellular Pathophysiology Of Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2002
- Core--Liver Cell CultureNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2001
- Regulation Of The Fibronectin Gene In Liver CellsFogarty International Center1996–1998
- Cellular Pathophysiology Of Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1994
- Matrix-Degrading Proteinases And Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1990
- Hematin Infusion For Symptoms In Hereditary Hepatic PorphyriaNational Center For Research Resources1985
- Core--Hepatocyte CultureNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
- Cellular Pathophysiology Of Hepatic FibrosisNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: